We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+28.08%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.67B
AUM Growth
-$456M
Cap. Flow
-$727M
Cap. Flow %
-43.59%
Top 10 Hldgs %
45.69%
Holding
80
New
7
Increased
16
Reduced
26
Closed
17

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$55M
2
UHS icon
Universal Health Services
UHS
+$15M
3
AVTR icon
Avantor
AVTR
+$13.9M
4
SYK icon
Stryker
SYK
+$13.1M
5
BSX icon
Boston Scientific
BSX
+$12.7M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$59.7M
2
CAH icon
Cardinal Health
CAH
+$55.5M
3
UNH icon
UnitedHealth
UNH
+$51.6M
4
BIIB icon
Biogen
BIIB
+$48M
5
IRTC icon
iRhythm Holdings
IRTC
+$45.8M

Sector Composition

Rank Sector Weight
1 Healthcare 96.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.04T
$174M 10.44%
298,643
– –
CYTK icon
2
Cytokinetics
CYTK
$11.2B
$147M 8.8%
1,757,192
-642,353
-27% -$23.3M
MRK icon
3
Merck
MRK
$315B
$65M 3.9%
596,261
– –
ABBV icon
4
AbbVie
ABBV
$448B
$63.1M 3.78%
407,013
-94,179
-19% -$13.7M
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$120B
$60.6M 3.63%
+148,852
New +$55M
HUM icon
6
Humana
HUM
$47.7B
$57.4M 3.44%
125,340
-40,726
-25% -$20.1M
EW icon
7
Edwards Lifesciences
EW
$48.6B
$56.4M 3.39%
740,260
+37,672
+5% +$2.62M
BDX icon
8
Becton Dickinson
BDX
$42.2B
$48.8M 2.93%
200,041
+46,086
+30% +$11.4M
MCK icon
9
McKesson
MCK
$95.3B
$45.1M 2.71%
97,498
– –
THC icon
10
Tenet Healthcare
THC
$16.8B
$44.5M 2.67%
589,409
+10,705
+2% +$679K
CNC icon
11
Centene
CNC
$32.5B
$41.4M 2.48%
557,751
-232,117
-29% -$16.7M
KRTX
12
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$41.2M 2.47%
130,293
-7,916
-6% -$1.54M
LEGN icon
13
Legend Biotech
LEGN
$4.55B
$40.9M 2.45%
679,076
– –
PEN icon
14
Penumbra
PEN
$12.4B
$39.2M 2.35%
155,786
-36,620
-19% -$8.09M
AXSM icon
15
Axsome Therapeutics
AXSM
$12.3B
$37.2M 2.23%
467,427
-55,783
-11% -$3.73M
CRBU icon
16
Caribou Biosciences
CRBU
$165M
$37.1M 2.23%
6,480,764
-243,951
-4% -$1.21M
HCA icon
17
HCA Healthcare
HCA
$82.5B
$33.8M 2.03%
124,840
+5,305
+4% +$1.31M
ARGX icon
18
argenx
ARGX
$53.3B
$33M 1.98%
86,832
-17,900
-17% -$8.34M
UHS icon
19
Universal Health Services
UHS
$9.04B
$30.8M 1.85%
202,292
+111,783
+124% +$15M
DHR icon
20
Danaher
DHR
$126B
$29M 1.74%
125,515
-72,663
-37% -$15.5M
ICLR icon
21
Icon
ICLR
$12.9B
$28.8M 1.73%
101,812
-111,747
-52% -$28.9M
TMO icon
22
Thermo Fisher Scientific
TMO
$196B
$27.2M 1.63%
51,328
-10,815
-17% -$5.23M
IQV icon
23
IQVIA
IQV
$33.1B
$25.9M 1.55%
111,854
-89,183
-44% -$18.3M
MOH icon
24
Molina Healthcare
MOH
$11.6B
$25.3M 1.52%
70,088
-73,691
-51% -$26M
ACHC icon
25
Acadia Healthcare
ACHC
$3.2B
$23.9M 1.44%
307,937
-69,932
-19% -$5.18M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q4 2023 Portfolio in Review

As of Q4 2023, PFM Health Sciences held 80 positions worth $1.67B, down 21% from $2.12B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

PFM Health Sciences withdrew a net $727M in Q4 2023, closing 17 positions and reducing 26 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $59.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Vertex Pharmaceuticals worth $60.6M.

  • PFM Health Sciences's largest Q4 2023 buy was Vertex Pharmaceuticals: 148,852 shares worth $60.6M.
  • PFM Health Sciences added most to Universal Health Services in Q4 2023, an estimated $15M increase.
  • PFM Health Sciences's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $51.6M.
  • PFM Health Sciences fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $59.7M.
  • PFM Health Sciences's ten largest holdings make up 46% of its $1.67B portfolio in Q4 2023.
  • PFM Health Sciences opened 7 new positions and closed 17 in Q4 2023.
  • PFM Health Sciences's portfolio value fell 21% quarter-over-quarter to $1.67B.

Based on PFM Health Sciences's 13F filing for Q4 2023, filed 14 Feb 2024.